Entinostat Neuroendocrine (NE) Tumor
NCT03211988
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
5
Enrollment
OTHER
Sponsor class
Stopped
Lack of funding and drug supply
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
Entinostat
Sponsor
Antonio Fojo